News|Articles|December 4, 2013
The Impact of Biosimilars on the Innovator Market
Author(s)Pharmaceutical Technology Editors
Jill E. Sackman, D.V.M., PhD, senior consultant at Numerof & Associates, Inc. discusses the market forces impacting biopharmaceutical manufacturing
Advertisement
Jill E. Sackman, D.V.M., PhD, senior consultant atNumerof & Associates, Inc. discusses the market forces impacting biopharmaceutical manufacturing.
For more videos tune in to:
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
BBB-Crossing Tech for Lysosomal Storage Disorders at Center of Chiesi–Aliada Partnership
2
UK’s Persistent Failure to Commercialize R&D Threatens Life Sciences: Report
3
Achieving a Personalized Digital Control Arm for Preclinical Drug Evaluation
4
At AAPS PharmSci 360, Solutions for Challenges in Amorphous Solid Dispersion Development
5
